Login

Investing in Southeast Asian companies|Jeffrey Paine,Managing Partner,Golden Gate 00:10:00

Share On Facebook Share On Twitter

One of the most active and respected startup ecosystem leaders in all of Asia.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
My Worst Money Mistake: Starting a Financial Career in Debt
00:10:00
exceptional founders solving hard problems that require intense curiosity|Max Levchin,General Partner,SciFi VC
00:10:00
Innovative Solutions for Mining Challenges: Transforming Safety and Efficiency
00:10:00
American Eagle Gold Reports Exciting New Drilling Results and Expands Exploration Program
00:10:00
Bridging Global Relations: Insights from Kirill Dmitriev | Kirill Dmitriev - CEO, Russian Direct Investment Fund
00:10:00
Phost's Breakthrough in Neurodegenerative Disease Treatment: CEO Michael Thern on Accelerated FDA Approval for Monipentel|Dr Michael Thurn,Managing Director & Chief Executive Officer,PharmAust Ltd.
00:10:00
Polished Bits_ Wireline bit troubleshooting information Technical information from Diaset| Robert Miller, President at Diaset Products Ltd
00:10:00
Create value by strategically transforming the companies we acquire|Ramzi Musallam,CEO,Veritas Capital
00:00:00
Ekso Bionics Holdings, Inc EKSO CEO Jack Peurach on 2019 Results
00:10:00
AMIS: Leading CRM Provider in Africa with 20 Years of Industry Expertise
00:10:00
CEO Rosario Pingaro Discusses the Future-Proof Vision of Convergenze: A Leading Multiutility | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:10:00
Understanding Good Debt vs. Bad Debt: Insights from Kade Hammes | Kade Hammes, Founder, Storybook Financial.

© 2026 Nehu